DOWNS-SYNDROME AND ALZHEIMERS-DISEASE - DENDRITIC SPINE COUNTS IN THE HIPPOCAMPUS

被引:166
|
作者
FERRER, I [1 ]
GULLOTTA, F [1 ]
机构
[1] UNIV MUNSTER, INST NEUROPATHOL, W-4400 MUNSTER, GERMANY
关键词
Alzheimer's disease; Dendritic spines; Down's syndrome; Golgi method; Hippocampus;
D O I
10.1007/BF00294247
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Samples of the hippocampus of four patients with Down's syndrome [two men aged 35 and 36 years with no evidence of Alzheimer's disease (AD) and two patients aged 47 and 55 years with associated AD] were obtained at post mortem and processed according to the rapid Golgi method. A significant reduction in the number of dendritic spines (DS) was found in the apical (middle, distal and oblique segments) and basilar (thick and thin segments) dendritic arbors of CA1 and CA2-3 pyramidal neurons in patients with Down's syndrome and no AD when compared to age-matched controls. An additional decrease of DS in every segment occurred in Down's patients with associated AD when compared to agematched controls and Down's patients with no AD. In Down's syndrome (either associated or not to AD) thin basilar dendrites were the most severely involved; in AD patients CA1 pyramids were more severely affected than pyramidal neurons of the CA2-3 subfield. © 1990 Springer-Verlag.
引用
收藏
页码:680 / 685
页数:6
相关论文
共 50 条
  • [41] GENETICS OF ALZHEIMERS-DISEASE - ASSOCIATIONS WITH HEMATOLOGIC MALIGNANCY AND DOWNS-SYNDROME
    HESTON, LL
    MASTRI, AR
    ARCHIVES OF GENERAL PSYCHIATRY, 1977, 34 (08) : 976 - 981
  • [42] PLASTICITY OF HIPPOCAMPAL CIRCUITRY IN ALZHEIMERS-DISEASE - IMPLICATION FOR DOWNS-SYNDROME
    GEDDES, JW
    COTMAN, CW
    LOTT, IT
    CLINICAL RESEARCH, 1987, 35 (01): : A226 - A226
  • [43] DOWNS-SYNDROME - PROPHYLAXIS AND THERAPY FOR THE FREQUENTLY COMORBID ALZHEIMERS-DISEASE
    OKEN, RJ
    MCGEER, PL
    MEDICAL HYPOTHESES, 1995, 44 (04) : 233 - 234
  • [44] MORPHOLOGICAL FEATURES OF PICKS AND ATYPICAL ALZHEIMERS-DISEASE IN DOWNS-SYNDROME
    POGACAR, S
    RUBIO, A
    ACTA NEUROPATHOLOGICA, 1982, 58 (04) : 249 - 254
  • [45] CORTICAL SOMATOSTATIN (SRIF) IS REDUCED IN ALZHEIMERS-DISEASE BUT NOT IN DOWNS-SYNDROME
    PIEROTTI, AR
    SIMPSON, J
    GORDON, A
    YATES, CM
    HARMAR, AJ
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1984, 20 (6B): : 1607 - 1607
  • [46] PATHOGENESIS OF AMYLOID FORMATION IN ALZHEIMERS-DISEASE, DOWNS-SYNDROME AND SCRAPIE
    WISNIEWSKI, HM
    WRZOLEK, M
    CIBA FOUNDATION SYMPOSIA, 1988, 135 : 224 - 238
  • [47] HIPPOCAMPAL GLUTAMATE RECEPTORS IN ALZHEIMERS-DISEASE - IMPLICATION FOR DOWNS-SYNDROME
    GEDDES, JW
    COTMAN, CW
    LOTT, IT
    ANNALS OF NEUROLOGY, 1986, 20 (03) : 430 - 430
  • [48] CEREBROVASCULAR AMYLOIDOSIS IN DOWNS-SYNDROME ADULTS - IMPLICATIONS IN ALZHEIMERS-DISEASE
    GLENNER, GG
    CLINICAL RESEARCH, 1984, 32 (01): : A55 - A55
  • [49] CASE OF DOWNS-SYNDROME WITH DIFFUSE LEWY BODY DISEASE AND ALZHEIMERS-DISEASE
    BODHIREDDY, S
    DICKSON, DW
    MATTIACE, L
    WEIDENHEIM, KM
    NEUROLOGY, 1994, 44 (01) : 159 - 161
  • [50] ALZHEIMERS-DISEASE AND DOWNS-SYNDROME - SHARING OF A NOVEL AMYLOID FIBRIL PROTEIN
    GLENNER, GG
    CLINICAL RESEARCH, 1985, 33 (01): : A69 - A69